| Absorption |
| Blood-Brain Barrier | BBB- | 0.9783 |
| Human Intestinal Absorption | HIA+ | 0.7469 |
| Caco-2 Permeability | Caco2+ | 0.5711 |
| P-glycoprotein Substrate | Substrate | 0.7366 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7968 |
| Non-inhibitor | 0.7036 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9536 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6915 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8145 |
| CYP450 2D6 Substrate | Non-substrate | 0.9036 |
| CYP450 3A4 Substrate | Substrate | 0.6805 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9088 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9232 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9081 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9058 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7561 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9954 |
| Non-inhibitor | 0.6783 |
| AMES Toxicity | Non AMES toxic | 0.8909 |
| Carcinogens | Non-carcinogens | 0.9091 |
| Fish Toxicity | High FHMT | 0.9569 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9553 |
| Honey Bee Toxicity | Low HBT | 0.6575 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7285 |
| Carcinogenicity (Three-class) | Non-required | 0.6844 |